Publications

5674 Results

Serum beta 2 microglobulin and IgM identify distinct prognostic subsets in patients with waldenstrom's macroglobulinemia (WM)

Authors
MV Dhodapkar;J Jacobson;M Gertz;SE Rivkin;GR Weiss;DR Gandara;RA Chapman;JJ Crowley;S Salmon;R Kyle;B Barlogie
Journal / Conference
Blood 94(10)Suppl.1:705a(#3115)part_1_of_2
Year
1999
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9003

A randomized phase III study of cyclosporine (CsA) modulation of anthracycline resistance in CML-blast phase: Southwest Oncology Group (SWOG) study 9032

Authors
AF List;KJ Kopecky;ML Slovak;CL Willman;DR Head;FR Appelbaum
Journal / Conference
Blood 94(10)Suppl.1:276b(#4445)part_2_of_2
Year
1999
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9032

Current status of chemotherapy for advanced non-small cell lung cancer: a perspective from the Southwest Oncology Group (SWOG)

Authors
DR Gandara;MJ Edelman;J Crowley
Journal / Conference
Revista de Oncologia 1(Suppl 2):17-19
Year
1999
Research Committee(s)
Lung

Preoperative chemotherapy in stage III non-small cell lung cancer: long -term outcome

Authors
DR Gandara;B Leigh;E Vallieres;KS Albain
Journal / Conference
Lung Cancer 26:3-6
Year
1999
Research Committee(s)
Lung
Study Number(s)
SWOG-8805, S9900

Frequent expression of hte tumor necrosis factor receptor associated factor-1 in LMP1-positive post transplant lymphoproliferative disease and HIV-associated lymphomas

Authors
PG Murray;LJ Swinnen;JR Flavell;MV Ragni;HT Hassan;D Lowe;C Schnell;J Johl;LS Young;RF Ambinder
Journal / Conference
Blood 94(10)Suppl.1:303a(#1353)part_1_of_2
Year
1999
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9239, SWOG-9320

Bcl-6 is not overexpressed in post-transplant lymphoproliferative disorder (PTLD)

Authors
CC Ye;LJ Swinnen;H Fan;TM Grogan;ML Gulley
Journal / Conference
Blood 94(10)Suppl.1:519a(#2322)part_1_of_2
Year
1999
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9239

24-color karyotyping (multiplex or M-fish) reveals chromosome aberrations in cytogenetically normal acute myeloid leukemia

Authors
ML Slovak;F Zhang;JL Murata-Collins;KJ Kopecky;CL Willman;SJ Forman;FR Appelbaum
Journal / Conference
Blood 94(10)Suppl.1:657a(#2918)part_1_of_2
Year
1999
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031

A randomized, phase III trial of mitoxantrone (M) + etoposide (E) versus daunomycin (D) + cytarabine (A) as induction therapy in pts over age 55 with previously untreated acute myeloid leukemia (AML): Southwest Oncology Group Study 9333

Authors
JE Anderson;KJ Kopecky;D Head;MR O'Donnell;FW Luthardt;TH Norwood;CL Willman;SP Balcerzak;DB Johnson;FR Appelbaum
Journal / Conference
Blood 94(10)Suppl.1:383a(#1702)part_1_of_2
Year
1999
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9333

Report of an international workshop to standardize response criteria for non-hodgkin's lymphomas

Authors
BD Cheson;SJ Horning;B Coiffier;MA Shipp;RI Fisher;JM Connors;TA Lister;J Vose;A Grillo-Lopez;A Hagenbeek;F Cabanillas;D Klippensten;W Hiddemann;R Castellino;NL Harris;JO Armitage;W Carter;R Hoppe;GP Canellos
Journal / Conference
Journal of Clinical Oncology 17(4):1244-1253
Year
1999
Research Committee(s)
Lymphoma

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099

Authors
M Al-Sarraf;M LeBlanc;PGS Giri;KK Fu;J Cooper;T Vuong;AA Forastiere;G Adams;WA Sakr;DE Schuller;JF Ensley
Journal / Conference
Classic Papers & Current Comments 4(3):649-656
Year
1999
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)